The two investment firms Kverva and Orkla are currently its two principal shareholders with 36.6 percent each.
Third largest shareholder is Morten Nordstad, managing director at the company, who through Sveen Gard Invest, owns 4.59 percent of the shares.
Pharmaq has many smaller shareholders, consisting of current and former employees of the company.
“Orkla’s strategy is to structure the investment portfolio and sell off financial assets.
